Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James M. Daly currently holds 388 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James M. Daly has been a net seller of HALO stock. They have purchased $0 and sold $39.0M worth of shares.
James M. Daly's most recent insider trade was on Apr 15, 2026, when they sold 191 shares at $65.37 per share.
James M. Daly serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 126 insider transactions totaling $39.0M over their tenure at the company.
James M. Daly holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
James M. Daly has shown a selling trading pattern, with $0 in total purchases and $39.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James M. Daly was on Apr 1, 2024, when they sold $2.0M worth of MDGL shares. This transaction involved 20,000 shares at $100.45 per share.
James M. Daly currently owns 388 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James M. Daly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James M. Daly has 126 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for James M. Daly and 40,000+ other insiders.